California Legislature · 2017-2018 Regular Session
Amended Senate
AB 2486
Opioid Prevention and Rehabilitation Act
Author:
Kevin McCarty
(D-AD07)
Show 1 co-author
James Gallagher
(R-AD03)
Latest action:
Amended Senate
(Jun 18, 2018)
Current location: CS60 · Committee
Version history
Action history
-
Feb 14, 2018 Read first time. To print. Assembly
-
Feb 15, 2018 From printer. May be heard in committee March 17. Assembly
-
Mar 22, 2018 Referred to Com. on HEALTH. Assembly
-
Mar 23, 2018 From committee chair, with author's amendments: Amend, and re-refer to Com. on HEALTH. Read second time and amended. Assembly
-
Apr 2, 2018 Re-referred to Com. on HEALTH. Assembly
-
Apr 25, 2018 From committee: Do pass and re-refer to Com. on APPR. (Ayes 12. Noes 2.) (April 24). Re-referred to Com. on APPR. Assembly
-
May 9, 2018 In committee: Set, first hearing. Referred to APPR. suspense file. Assembly
-
May 25, 2018 Read second time. Ordered to third reading. Assembly
-
May 25, 2018 From committee: Do pass. (Ayes 13. Noes 1.) (May 25). Assembly
-
May 31, 2018 Read third time. Passed. Ordered to the Senate. (Ayes 65. Noes 1. Page 5593.) Assembly
-
Jun 4, 2018 In Senate. Read first time. To Com. on RLS. for assignment. Senate
-
Jun 13, 2018 Referred to Com. on HEALTH. Senate
-
Jun 18, 2018 From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on HEALTH. Senate
-
Jun 25, 2018 In committee: Hearing postponed by committee. Senate
-
Aug 13, 2018 In committee: Set, first hearing. Hearing canceled at the request of author. Senate
Votes recorded
1 vote
May 31, 2018 · Assembly Floor
AB 2486 MCCARTY Assembly Third Reading
Tally
65
·
1
·
12
PASS
Democrat
51/0/1
Republican
13/1/11
Other
1/0/0
Aye
(65)
Cecilia Aguiar-Curry
(D-AD04)
Joaquin Arambula
(D-AD31)
Marc Berman
(D-AD24)
Richard Bloom
(D-AD50)
Rob Bonta
(D-AD18)
Autumn Burke
(D-AD62)
Anna Caballero
(D-AD30)
Ian Charles Calderon
(D-AD57)
Wendy Carrillo
(D-AD51)
Sabrina Cervantes
(D-AD60)
Ed Chau
(D-AD49)
David Chiu
(D-AD17)
Kansen Chu
(D-AD25)
Ken Cooley
(D-AD08)
Jim Cooper
(D-AD09)
Cristina Garcia
(D-AD58)
Tom Daly
(D-AD69)
Eduardo Garcia
(D-AD56)
Susan Talamantes Eggman
(D-AD13)
Jim Frazier
(D-AD11)
Laura Friedman
(D-AD43)
Mike Gipson
(D-AD64)
Adam Gray
(D-AD21)
Timothy Grayson
(D-AD14)
Chris Holden
(D-AD41)
Jacqui Irwin
(D-AD44)
Reginald Byron Jones-Sawyer
(D-AD59)
Ash Kalra
(D-AD27)
Sydney Kamlager
(D-AD54)
Marc Levine
(D-AD10)
Monique Limón
(D-AD37)
Evan Low
(D-AD28)
Mark Stone
(D-AD29)
Kevin McCarty
(D-AD07)
Jose Medina
(D-AD61)
Kevin Mullin
(D-AD22)
Al Muratsuchi
(D-AD66)
Adrin Nazarian
(D-AD46)
Patrick O'Donnell
(D-AD70)
Bill Quirk
(D-AD20)
Sharon Quirk-Silva
(D-AD65)
Anthony Rendon
(D-AD63)
Eloise Gómez Reyes
(D-AD47)
Freddie Rodriguez
(D-AD52)
Blanca Rubio
(D-AD48)
Rudy Salas
(D-AD32)
Miguel Santiago
(D-AD53)
Tony Thurmond
(D-AD15)
Philip Ting
(D-AD19)
Shirley Weber
(D-AD79)
Jim Wood
(D-AD02)
Dante Acosta
(R-AD38)
Catharine Baker
(R-AD16)
Rocky Chávez
(R-AD76)
Phillip Chen
(R-AD55)
Jordan Cunningham
(R-AD35)
Brian Dahle
(R-AD01)
James Gallagher
(R-AD03)
Matthew Harper
(R-AD74)
Tom Lackey
(R-AD36)
Brian Maienschein
(R-AD77)
Devon Mathis
(R-AD26)
Melissa Melendez
(R-AD67)
Marie Waldron
(R-AD75)
Gonzalez Fletcher
No
(1)
Randy Voepel
(R-AD71)
Abstain / Other
(12)
Todd Gloria
(D-AD78)
Franklin Bigelow
(R-AD05)
William Brough
(R-AD73)
Steven Choi
(R-AD68)
Heath Flora
(R-AD12)
Vince Fong
(R-AD34)
Kevin Kiley
(R-AD06)
Chad Mayes
(R-AD42)
Jay Obernolte
(R-AD33)
Jim Patterson
(R-AD23)
Marc Steinorth
(R-AD40)
Travis Allen
(R-AD72)
Lobbying activity
FPPC lobbying disclosures whose activity descriptions mention AB 2486, scoped to filings whose coverage period extends through or beyond this bill's introduction date.
Note: CalAccess lobby filings reference bills by measure number only — no session tag. When the same measure number has existed in earlier sessions (e.g. a previously chaptered bill still being lobbied on for implementation), some of those filings may appear here even though they relate to a different bill. Use the activity descriptions to disambiguate.
| Period | Form | Filer | Firm / Employer | Lobbying Activity | Filing |
|---|---|---|---|---|---|
| 10/01/2018–12/31/2018 | Employer Report | Pfizer Inc. | Pfizer Inc. | AB 315, 444, 587, 595, 1368, 1512, 1752, 1860, 1919, 1992, 1998, 2029, 2303, 2346, 2395, 2486, 2490, 2499, 2517, 2560, 2674, 2741, 2789, 2863, 3087, 3138; ACR 162; ACA 22; SB 199, 212, 437, 562, 790, 826, 945, 993, 1021, 1121, 1156, 1398, 1426; SCR: 100, 109 | #2349758 |
| 07/01/2018–09/30/2018 | Employer Report | ABBVIE | — | AB 1860, 2486, 2863, SB 826, 945, 1021; SB 17 Implementation Legislature, OSHPD | #2315833 |
| 07/01/2018–09/30/2018 | Employer Report | ALKERMES, INC. | — | AB 2487, AB 2384, AB 2486 & SB 212. Legislature: Patient access parity for all Medication Assisted Treatments in publicly funded programs. Budget: Proposed Reimbursement for Narcotic Treatment Program (NTP) use of Naltrexone. Agencies: OSHPD: SB 17 implementation. | #2310728 |
| 07/01/2018–09/30/2018 | Employer Report | American Cancer Society Cancer Action Network Inc. | American Cancer Society Cancer Action Network Inc. | AB 937, 1335, 1810, 1838, 1860, 2174, 2275, 2335, 2434, 2459, 2486, 2499, 2565, 2275, 2863; ACR 163; SB 840, 910, 1108, 1192, 1255; SCR 143 | #2318448 |
| 07/01/2018–09/30/2018 | Employer Report | AMERISOURCEBERGEN CORPORATION | — | Board of Pharmacy re: Pharmaceutical Product Stewardship Programs, Compounding; Legislature, Governor's Office, CalRecycle, Board of Pharmacy re: Pharmaceutical Pricing, AB 315, 2486, 2560, SB 212, 641 | #2312945 |
| 07/01/2018–09/30/2018 | Employer Report | BIOCOM | — | Legislature: SB 212, SB 1121, SB 826, SB 1249, AB 2486, AB 1751, SB 327, SB 237, SB 456, AB 1860, AB 2384, AB 2486, AB 2487, SB 1021 Governor's Office: SB 212, SB 1121, AB 1751, AB 1860, AB 2384 Dep?t of Resources, Recycling & Recovery: SB 212 Cal EPA: SB 212 OSHPD SB 17 implementation | #2328568 |
| 07/01/2018–09/30/2018 | Employer Report | BRISTOL-MYERS SQUIBB COMPANY | — | Agencies: Legislature & Governor's Office Issues: AB 375, 2486; SB 212, 1121; 340B | #2311704 |
| 07/01/2018–09/30/2018 | Employer Report | CALIFORNIA CHRONIC CARE COALITION | — | Legislature: AB315, AB595, AB613, AB845, AB870, AB1534, AB1860, AB1998, AB2384, AB2486, AB2499, AB2674, AB2760, AB2863, AB2893, SB437, SB910, SB1021, SB1108, SB1125, SB1156, SB1264. | #2318693 |
| 07/01/2018–09/30/2018 | Employer Report | CALIFORNIA TAXPAYERS ASSOCIATION AND AFFILIATED ENTITY CALIFORNIA TAX FOUNDATION | — | CALIFORNIA STATE LEGISLATURE REGARDING AB 2458, AB 2486, AB 2503, AB 2920, SB 152, SB 274. | #2320497 |
| 07/01/2018–09/30/2018 | Employer Report | CARDINAL HEALTH, INC. | CARDINAL HEALTH, INC. | AB 315, 2486; SB 212 | #2318728 |
| 07/01/2018–09/30/2018 | Employer Report | ENDO | — | Legislature: AB2486, SB212; OSHPD: SB 17 Implementation | #2319625 |
| 07/01/2018–09/30/2018 | Employer Report | EXPRESS SCRIPTS HOLDING COMPANY | — | State Legislature: AB 315, AB 2863, AB 2486; Governor's Office: AB 315; Department of Managed Health Care: AB 315. | #2308205 |
| 07/01/2018–09/30/2018 | Employer Report | HEALTHCARE DISTRIBUTION ALLIANCE (HDA) | HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) | AB 2486, 2789; SB 212; LEGISLATURE, GOVERNOR'S OFFICE RE: SHARPS/TAKEBACK, EDUCATION AT WHOLESALE SUPPLY CHAIN, OPIOD EFFORTS | #2317779 |
| 07/01/2018–09/30/2018 | Employer Report | MALLINCKRODT, LLC | — | AB 2384; AB 2486; SB 212; SB 1121 | #2310970 |
| 07/01/2018–09/30/2018 | Employer Report | MC KESSON CORPORATION | — | Legislature, Governor's Office, Board of Pharmacy, CalRecycle re: AB 315, 1751, 1752, 1753, 2086, 2256, 2486, 2760, 2789 and SB 212, 1109 and SR 82 and Opioid Abuse Policy, Opioid Tax Policy, Implementation of SB 212 | #2318976 |
| 07/01/2018–09/30/2018 | Employer Report | MYLAN INC. | MYLAN INC. | Legislature: SB 1021; SB 212; AB 2486. | #2318542 |
| 07/01/2018–09/30/2018 | Employer Report | NATIONAL ASSOCIATION OF CHAIN DRUG STORES | NATIONAL ASSOCIATION OF CHAIN DRUG STORES | Lobbied the Legislature and the Governor's office regarding AB 2789, AB 1751, AB 1753, AB 1998, and SB 1121. Lobbied the Governor's office regarding AB 2256. Lobbied the Legislature regarding AB 2486, SB 212 and SB 456. | #2320805 |
| 07/01/2018–09/30/2018 | Employer Report | NOVARTIS SERVICES, INC | — | AB 587,595,1860,1955,2275, 2277,2384,2416,2427,2428, 2459,2472,2486,2489,2499, 2502,2517,2565,2566,2624, 2632,2653,2674,2741,2793, 2863,2893,2935,2965,3148, 1121 SB 66,199,212,288,437,790, 954,974,993,1021,1255,1264,1285,1287,1322,1375,1398, 1426 SCR 109, ACA 22, ACR 162, HR 83, Continued | #2311785 |
| 07/01/2018–09/30/2018 | Employer Report | Pfizer Inc. | Pfizer Inc. | AB 315, 444, 587, 595, 1368, 1512, 1752, 1860, 1919, 1992, 1998, 2029, 2303, 2346, 2395, 2486, 2490, 2499, 2517, 2560, 2674, 2741, 2789, 2863, 3087, 3138; ACR 162; ACA 22; SB 199, 212, 437, 562, 790, 826, 945, 993, 1021, 1121, 1156, 1398, 1426; SCR: 100, 109 | #2317338 |
| 07/01/2018–09/30/2018 | Employer Report | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | AB 2384, 2486, 3087; SB 212; AB 1512; AB 212, 315; AB 1860, 2863; ACR 175; SB 826, 945, 1021; SB 17 IMPLEMENTATION; AB 374, AB 1512, SB 1121, SB 456, 790 | #2319695 |
| 07/01/2018–09/30/2018 | Employer Report | PURDUE PHARMA LP | PURDUE PHARMA LP | Legislature: AB 2486. | #2315481 |
| 04/01/2018–06/30/2018 | Employer Report | ABBVIE | — | AB 1860, 2486, 2863, ACR 175, SB 826, 945, 1021; SB 17 Implementation | #2274354 |
| 04/01/2018–06/30/2018 | Employer Report | ALKERMES, INC. | — | Legislative: Patient access parity for all Medication Assisted Treatment in publicly funded programs. AB 1963, AB 2487, AB 2384 & AB 2486. Budget: Proposed Reimbursement for Narcotic Treatment Program (NTP) use of Naltrexone. OSHPD: SB 17 implementation. | #2270445 |
| 04/01/2018–06/30/2018 | Employer Report | American Cancer Society Cancer Action Network Inc. | American Cancer Society Cancer Action Network Inc. | AB 158, 937, 1335, 1838, 1998, 2020, 2275, 2335, 2434, 2459, 2486, 2499, 2565, 2775, 2863; ACR 163; SB 872, 910, 945, 1108, 1192, 1255; SCR 143; Tobacco Education Research Oversight Committee, California Department of Finance: multi-year spending authority for Prop. 56 funded programs | #2271754 |
| 04/01/2018–06/30/2018 | Employer Report | AMERISOURCEBERGEN CORPORATION | — | Board of Pharmacy re: Pharmaceutical Product Stewardship Programs, Compounding; Legislature re: Pharmaceutical Pricing, AB 182, 315, 444, 587, 2174, 2486, 2560, SB 212, 641 | #2270642 |
| 04/01/2018–06/30/2018 | Employer Report | ASSOCIATION FOR ACCESSIBLE MEDICINES | — | AB 2486; SB 212 | #2271950 |
| 04/01/2018–06/30/2018 | Employer Report | BIOCOM | — | Legislature: SB 826, SB 212, AB 1902, AB 1751, AB 2486, AB 2487, AB 3087, AB 2731, AB 3217, AB 2855, SB 1249, AB 710, SB 993, AB 1860, AB 1963, AB 2384, SB 1021 Governor's Office: SB 212 OSHPD: SB 17 implementation | #2271815 |
| 04/01/2018–06/30/2018 | Employer Report | CALIFORNIA CHRONIC CARE COALITION | — | Legislature: AB315, AB1860, AB1963, AB1998, AB2174, AB2384, AB2486, AB2499, AB2502, AB2674, AB2741, AB2760, AB2863, AB2893, AB3087, SB910, SB945, SB1021, SB1108, SB1125, SB1156, SB1264, SCR74 | #2272125 |
| 04/01/2018–06/30/2018 | Employer Report | CALIFORNIA TAXPAYERS ASSOCIATION AND AFFILIATED ENTITY CALIFORNIA TAX FOUNDATION | — | CALIFORNIA STATE LEGISLATURE REGARDING AB 2351, AB 2458, AB 2486, AB 2503, AB 2731, AB 2855, AB 2920, AB 3122, SB 66, SB 274, SB 863, SB 958, SB 993, SB 1082, SB 1398, SB 1508 AND SCA 22. | #2273660 |
| 04/01/2018–06/30/2018 | Employer Report | CARDINAL HEALTH, INC. | CARDINAL HEALTH, INC. | AB 2486; SB 212 | #2276433 |
| 04/01/2018–06/30/2018 | Employer Report | ENDO | — | Legislature: AB 444, AB2486, SB212, SB790; OSHPD: SB 17 Implementation | #2269905 |
| 04/01/2018–06/30/2018 | Employer Report | HEALTHCARE DISTRIBUTION ALLIANCE (HDA) | HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) | AB 2486, 2789; SB 212; LEGISLATURE RE: SHARPS/TAKEBACK, EDUCATION AT WHOLESALE SUPPLY CHAIN, OPIOD EFFORTS | #2273701 |
| 04/01/2018–06/30/2018 | Employer Report | INDEPENDENT PHARMACY COOPERATIVE | INDEPENDENT PHARMACY COORPERATIVE | AB 315, 2486, 2589; SB 212 | #2271825 |
| 04/01/2018–06/30/2018 | Employer Report | MALLINCKRODT, LLC | — | AB 2384; AB 2486; SB 212 | #2265977 |
| 04/01/2018–06/30/2018 | Employer Report | MC KESSON CORPORATION | — | Legislature, Governor's Office, Board of Pharmacy re: AB 315, 444, 1751, 1752, 1753, 2086, 2256, 2486, 2760, 2789 and SB 212, 1109 and SR 82 and Opioid Abuse Policy | #2272758 |
| 04/01/2018–06/30/2018 | Employer Report | MERCK SHARP & DOHME CORP. AND ITS AFFILIATES | MERCK SHARP & DOHME CORP. AND ITS AFFILIATES | AB 212, 2486, 2589, 2859; SB 17, 212, 945, 1021 | #2276414 |
| 04/01/2018–06/30/2018 | Employer Report | NOVARTIS SERVICES, INC | — | AB 587, 595, 1860, 1955, 2275, 2277, 2384, 2416, 2427, 2428, 2459, 2472, 2486, 2489, 2499, 2502, 2517, 2565, 2566, 2624, 2632, 2653, 2674, 2741, 2783, 2863, 2893, 2935, 2965, 3148. ACA 22, 162. HR 83. SCR 109. SB 66, 199, 212, 288, 437, 790, 945, 974, 993, 1021, 1255, 1264, 1285, 1287, 1322, 1375, 1398, 1426, Con't | #2265111 |
| 04/01/2018–06/30/2018 | Employer Report | Pfizer Inc. | Pfizer Inc. | AB 315, 444, 587, 595, 1368, 1512, 1752, 1860, 1919, 1992, 1998, 2029, 2303, 2346 2395, 2486, 2490, 2499, 2517, 2560, 2674, 2741, 2789, 2863, 3087, 3138; ACR 162; ACA 22; SB 199, 212, 437, 562, 790, 826, 945, 993, 1021, 1156, 1398, 1426; SCR: 100, 109 | #2274670 |
| 04/01/2018–06/30/2018 | Employer Report | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | AB 2384, 2486, 3087; SB 212; AB 1512; AB 212, 315; AB 1860, 2863; ACR 175; SB 826, 945, 1021; SB 17 IMPLEMENTATION | #2270364 |
| 04/01/2018–06/30/2018 | Employer Report | PURDUE PHARMA LP | PURDUE PHARMA LP | Legislature: AB 2486; SB 1109. | #2271010 |
| 01/01/2018–03/31/2018 | Employer Report | AMERISOURCEBERGEN CORPORATION | — | Board of Pharmacy re: Pharmaceutical Product Stewardship Programs, Compounding; Legislature re: Pharmaceutical Pricing, AB 182, 315, 444, 587, 2174, 2486, 2560, SB 641 | #2233352 |
| 01/01/2018–03/31/2018 | Employer Report | CALIFORNIA CHRONIC CARE COALITION | — | Legislature: AB315, AB1860, AB1963, AB1998, AB2174, AB2384, AB2486, AB2674, AB2741, AB2863, SB910, SB945, SB1021, SB1125, SCR74 | #2236669 |
| 01/01/2018–03/31/2018 | Employer Report | CARDINAL HEALTH, INC. | CARDINAL HEALTH, INC. | AB 186, 444, 2110, 2486 | #2242518 |
| 01/01/2018–03/31/2018 | Employer Report | ENDO | — | Legislature: AB2486, SB790; OSHPD: SB 17 Implementation | #2236769 |
| 01/01/2018–03/31/2018 | Employer Report | MC KESSON CORPORATION | — | Legislature, Governor's Office, Board of Pharmacy re: AB 29, 40, 182, 265, 315, 401, 444, 587, 715, 1048, 1512, 1751, 1752, 1753, 1963, 1998, 2174, 2256, 2384, 2486, 2487, 2741, 2760, 2789, 2804, 2859, 2861 and SB 17, 212, 443, 1103, 1109, 1229, 1240 and Opioid Abuse Policy and ePrescribing legislation | #2237362 |
| 01/01/2018–03/31/2018 | Employer Report | NOVARTIS SERVICES, INC | — | AB 587, 595, 1860, 1955, 2275, 2277, 2384, 2416, 2427, 2428, 2459, 2472, 2486, 2489, 2499, 2502, 2517, 2565, 2566, 2624, 2632, 2653, 2674, 2741, 2783, 2863, 2893, 2935, 2965, 3148, ACA 22, 162, 83, SB 66, 199, 212, 288, 437, 790, 945, 974, 993, 1021, 1255, 1264, 1285, 1287, 1322, 1375, 1398, 1426, SCR 109, continued | #2235533 |
| 01/01/2018–03/31/2018 | Employer Report | PURDUE PHARMA LP | PURDUE PHARMA LP | Legislature: AB 2486; SB 1109. | #2240294 |
| Period | Form | Employer | Firm / Filer | Fees | Reimb. | Period Total | Cumulative | Lobbying Activity | Filing |
|---|---|---|---|---|---|---|---|---|---|
| 07/01/2018–09/30/2018 | Firm Activity (payments) | ABBVIE | FERNANDEZ CERVANTES GOVERNMENT AFFAIRS | $18,150 | $0 | $18,150 | $54,450 | AB 1860, 2486, 2863, SB 826, 945, 1021; Legislature and Office of Health Planning & Development Re: SB 17 Implementation | #2318160 |
| 07/01/2018–09/30/2018 | Firm Activity (payments) | Alkermes | WILKE, FLEURY, HOFFELT, GOULD & BIRNEY, LLP | $18,000 | $62 | $18,062 | $97,370 | Legislature: AB2487, AB2384, AB2486 & SB212; patient access parity for Medication Assisted Treatments in publicly funded programs; See Memo | #2320140 |
| 07/01/2018–09/30/2018 | Firm Activity (payments) | BIOCOM | SLOAT HIGGINS JENSEN AND ASSOCIATES, LLC | $27,000 | $0 | $27,000 | $189,419 | AB 1751, 1860, 2384, 2486, 2487; SB 212, 237, 327, 456, 826, 1021, 1121, 1249; OFFICE OF STATEWIDE HEALTH PLANNING AND DEVELOPMENT RE: SB 17 IMPLEMENTATION | #2320554 |
| 07/01/2018–09/30/2018 | Firm Activity (payments) | BRISTOL-MYERS SQUIBB COMPANY | POLITICAL SOLUTIONS, LLC | $60,000 | $0 | $60,000 | $244,194 | AB 375, 2486; SB 212, 1121; 340B | #2320363 |
| 07/01/2018–09/30/2018 | Employer Payments to Firms | Capitol Partners LLC | MYLAN INC. | $21,000 | $0 | $21,000 | $126,000 | Legislature: SB 1021; SB 212; AB 2486. | #2318542 |
| 07/01/2018–09/30/2018 | Firm Activity (payments) | Endo | WILKE, FLEURY, HOFFELT, GOULD & BIRNEY, LLP | $15,000 | $0 | $15,000 | $98,002 | Legislature: AB2486, SB212; OSHPD: SB 17 Implementation | #2320140 |
| 07/01/2018–09/30/2018 | Firm Activity (payments) | EXPRESS SCRIPTS HOLDING COMPANY | SLOAT HIGGINS JENSEN AND ASSOCIATES, LLC | $18,000 | $0 | $18,000 | $126,000 | AB 315, 2486, 2863 | #2320554 |
| 07/01/2018–09/30/2018 | Firm Activity (payments) | MALLINCKRODT, LLC | NOTEWARE AND ROSA GOVERNMENT RELATIONS | $18,000 | $0 | $18,000 | $126,000 | AB 2384, 2486; SB 212, 1121 | #2310634 |
| 07/01/2018–09/30/2018 | Employer Payments to Firms | Matt Back Government Relations | PURDUE PHARMA LP | $21,000 | $0 | $21,000 | $148,023 | Legislature: AB 2486. | #2315481 |
| 07/01/2018–09/30/2018 | Firm Activity (payments) | McKesson Corporation | APREA & MICHELI, INC. | $23,625 | $0 | $23,625 | $173,440 | Legislature, Governor's Office, Board of Pharmacy, CalRecycle re: AB 315, 1751, 1752, 1753, 2086, 2256, 2486, 2760, 2789 and SB 212, 1109 and SR 82 and Opioid Abuse Policy, Opioid Tax Policy, | #2319042 |
| 07/01/2018–09/30/2018 | Firm Activity (payments) | Mylan, Inc. | Capitol Partners, LLC | $21,000 | $0 | $21,000 | $126,000 | SB 1021, SB 212, AB 2486 | #2319071 |
| 07/01/2018–09/30/2018 | Firm Activity (payments) | PFIZER, INC. | KAHN CONSULTING; CHRIS | $48,000 | $0 | $48,000 | $337,220 | CALIFORNIA STATE LEGISLATURE REGARDING AB 315, AB 1752, AB 1860, AB 1992, AB 1998, AB 2346, AB 2486, AB 2499, AB 2517, AB 2863, SB 212, SB 790, SB 945, SB 1021, SB 1121, ACR 162, SCR 109. | #2320513 |
| 07/01/2018–09/30/2018 | Firm Activity (payments) | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | NOTEWARE AND ROSA GOVERNMENT RELATIONS | $67,333 | $0 | $67,333 | $344,199 | AB 2384, 2486, 315; SB 212, SB 456, SB 790 | #2310634 |
| 07/01/2018–09/30/2018 | Firm Activity (payments) | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) | FERNANDEZ CERVANTES GOVERNMENT AFFAIRS | $20,000 | $0 | $20,000 | $45,000 | AB 1860, 2486, 2863, SB 826, 945, 1021; Legislature re: SB 17 Implementation | #2318160 |
| 07/01/2018–09/30/2018 | Firm Activity (payments) | Purdue Pharma LP | Matt Back Government Relations | $21,000 | $0 | $21,000 | $148,023 | Legislature regarding AB 2486 | #2316731 |
| 04/01/2018–06/30/2018 | Firm Activity (payments) | ABBVIE | FERNANDEZ GOVERNMENT SOLUTIONS, LLC | $18,150 | $0 | $18,150 | $36,300 | AB 1860, 2486, 2863, ACR 175, SB 826, 945, 1021; Legislature and Office of Health Planning & Development Re: SB 17 Implementation | #2276477 |
| 04/01/2018–06/30/2018 | Firm Activity (payments) | Alkermes | WILKE, FLEURY, HOFFELT, GOULD & BIRNEY, LLP | $18,000 | $128 | $18,128 | $67,300 | Legislature: AB1963, AB2384, AB2486, AB2487, Patient access parity for all Medication Assisted Treatments in publicly funding programs; OSHPD: SB 17 implementation; - Continued in Memo. | #2276754 |
| 04/01/2018–06/30/2018 | Firm Activity (payments) | BIOCOM | SLOAT HIGGINS JENSEN AND ASSOCIATES, LLC | $27,000 | $0 | $27,000 | $162,419 | AB 710, 1751, 1860, 1902, 1963, 2384, 2486, 2487, 2731, 2855, 3087, 3217; SB 212, 826, 993, 1021, 1249; OFFICE OF STATEWIDE HEALTH PLANNING AND DEVELOPMENT RE: SB 17 IMPLEMENTATION | #2274129 |
| 04/01/2018–06/30/2018 | Firm Activity (payments) | California Chronic Care Coalition | WILKE, FLEURY, HOFFELT, GOULD & BIRNEY, LLP | $9,000 | $186 | $9,186 | $54,217 | Legislature: AB315, AB1860, AB1963, AB1998, AB2174, AB2384, AB2486, AB2499, AB2502, AB2674, AB2741, AB2760, AB2863, AB2893, AB3087, SB910, SB945, SB1021, SB1108 - Continued in Memo. | #2276754 |
| 04/01/2018–06/30/2018 | Firm Activity (payments) | CALIFORNIA HOSPICE & PALLIATIVE CARE ASSOCIATION | CLEAR ADVOCACY, LLC | $9,000 | $0 | $9,000 | $54,000 | SB 944; AB 2486; SB 1447 | #2275651 |
| 04/01/2018–06/30/2018 | Firm Activity (payments) | CARDINAL HEALTH & AFFILIATED ENTTIES | NIELSEN MERKSAMER PARRINELLO GROSS & LEONI LLP | $26,500 | $150 | $26,650 | $152,254 | AB 2486; SB 212 | #2276788 |
| 04/01/2018–06/30/2018 | Firm Activity (payments) | CLEAR ADVOCACY, LLC (ON BEHALF OF ASSOCIATION FOR ACCESSIBLE MEDICINES) | KELLISON COMPANY, INC. | $15,000 | $0 | $15,000 | $128,042 | AB 2486; SB 212 | #2275468 |
| 04/01/2018–06/30/2018 | Firm Activity (payments) | CLEAR ADVOCACY, LLC (ON BEHALF OF CA HOSPICE & PALLIATIVE CARE ASSN) | KELLISON COMPANY, INC. | $9,000 | $0 | $9,000 | $54,000 | SB 944; AB 2486, SB 1447 | #2275468 |
| 04/01/2018–06/30/2018 | Firm Activity (payments) | Endo | WILKE, FLEURY, HOFFELT, GOULD & BIRNEY, LLP | $25,000 | $2 | $25,002 | $83,002 | Legislature: AB444, AB2486, SB212, SB790; OSHPD: SB 17 Implementation. | #2276754 |
| 04/01/2018–06/30/2018 | Firm Activity (payments) | HEALTHCARE DISTRIBUTION ALLIANCE (HDMA) | POLITICAL SOLUTIONS, LLC | $28,500 | $262 | $28,762 | $159,407 | AB 2486, 2789; SB 212; LEGISLATURE RE: SHARPS/TAKEBACK, EDUCATION AT WHOLESALE SUPPLY CHAIN, OPIOD EFFORTS | #2273593 |
| 04/01/2018–06/30/2018 | Firm Activity (payments) | INDEPENDENT PHARMACY COOPERATIVE | NIELSEN MERKSAMER PARRINELLO GROSS & LEONI LLP | $6,000 | $267 | $6,267 | $39,434 | AB 2486, 2589; SB 212 | #2276788 |
| 04/01/2018–06/30/2018 | Firm Activity (payments) | JOHNSON & JOHNSON SERVICES, INC. AND AFFILIATED ENTITIES | NIELSEN MERKSAMER PARRINELLO GROSS & LEONI LLP | $15,512 | $462 | $15,974 | $69,122 | AB 2486; SB 212, 945, 1021 | #2276788 |
| 04/01/2018–06/30/2018 | Firm Activity (payments) | MALLINCKRODT, LLC | NOTEWARE AND ROSA GOVERNMENT RELATIONS | $18,000 | $0 | $18,000 | $108,000 | AB 2384, 2486; SB 212 | #2267168 |
| 04/01/2018–06/30/2018 | Employer Payments to Firms | Matt Back Government Relations | PURDUE PHARMA LP | $21,000 | $0 | $21,000 | $127,023 | Legislature: AB 2486; SB 1109. | #2271010 |
| 04/01/2018–06/30/2018 | Firm Activity (payments) | McKesson Corporation | APREA & MICHELI, INC. | $23,625 | $0 | $23,625 | $149,815 | Legislature, Governor's Office, Board of Pharmacy re: AB 315, 444, 1751, 1752, 1753, 2086, 2256, 2486, 2760, 2789 and SB 212, 1109 and SR 82 and Opioid Abuse Policy | #2272304 |
| 04/01/2018–06/30/2018 | Firm Activity (payments) | MERCK SHARP & DOHME CORP. AND ITS AFFILIATES | NIELSEN MERKSAMER PARRINELLO GROSS & LEONI LLP | $0 | $0 | $0 | $82,190 | AB 212, 2486, 2859; SB 212, 945, 1021 | #2276788 |
| 04/01/2018–06/30/2018 | Firm Activity (payments) | Mylan, Inc. | Capitol Partners, LLC | $21,000 | $0 | $21,000 | $105,000 | SB 1021, SB 212, AB 2486 | #2275021 |
| 04/01/2018–06/30/2018 | Firm Activity (payments) | PFIZER, INC. | KAHN CONSULTING; CHRIS | $64,000 | $0 | $64,000 | $289,220 | CALIFORNIA STATE LEGISLATURE REGARDING AB 315, AB 1752, AB 1860, AB 1992, AB 1998, AB 2346, AB 2486, AB 2499, AB 2517, AB 2863, SB 212, SB 790, SB 945, SB 1021, ACR 162, SCR 109. | #2273681 |
| 04/01/2018–06/30/2018 | Firm Activity (payments) | Pharmaceutical Research and Manufacturers of America | GLADFELTY GOVERNMENT RELATIONS | $43,000 | $0 | $43,000 | $242,787 | Legislature // AB1512 AB2486 AB3087 SB212 | #2264880 |
| 04/01/2018–06/30/2018 | Firm Activity (payments) | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | NOTEWARE AND ROSA GOVERNMENT RELATIONS | $50,500 | $0 | $50,500 | $276,866 | AB 2384, 2486, 3087; SB 212 | #2267168 |
| 04/01/2018–06/30/2018 | Firm Activity (payments) | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | CAPITOL STRATEGIES GROUP, INC. | $21,000 | $0 | $21,000 | $35,000 | AB 212, AB 315, AB 2486, AB 3087, SB 212, and AB 2384 | #2276746 |
| 04/01/2018–06/30/2018 | Firm Activity (payments) | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) | FERNANDEZ GOVERNMENT SOLUTIONS, LLC | $15,000 | $0 | $15,000 | $25,000 | AB 1860, 2486, 2863, ACR 175, SB 826, 945, 1021; SB 17 Implementation | #2276477 |
| 04/01/2018–06/30/2018 | Firm Activity (payments) | Purdue Pharma LP | Matt Back Government Relations | $21,000 | $0 | $21,000 | $127,023 | Legislature regarding AB 2486 SB 1109 | #2269263 |
| 01/01/2018–03/31/2018 | Firm Activity (payments) | California Chronic Care Coalition | WILKE, FLEURY, HOFFELT, GOULD & BIRNEY, LLP | $12,000 | $0 | $12,000 | $45,243 | Legislature: AB315, AB1860, AB1963, AB1998, AB2174, AB2384, AB2486, AB2674, AB2741, AB2863, SB910, SB945, SB1021, SB1125, SCR74. | #2242516 |
| 01/01/2018–03/31/2018 | Firm Activity (payments) | Endo | WILKE, FLEURY, HOFFELT, GOULD & BIRNEY, LLP | $5,000 | $0 | $5,000 | $58,000 | Legislature: AB2486, SB790; OSHPD: SB 17 Implementation. | #2242516 |
| 01/01/2018–03/31/2018 | Employer Payments to Firms | Matt Back Government Relations | PURDUE PHARMA LP | $21,000 | $0 | $21,000 | $106,023 | Legislature: AB 2486; SB 1109. | #2240294 |
| 01/01/2018–03/31/2018 | Firm Activity (payments) | McKesson Corporation | APREA & MICHELI, INC. | $23,625 | $0 | $23,625 | $126,190 | Legislature, Governor's Office, Board of Pharmacy re: AB 29, 40, 182, 265, 315, 401, 444, 587, 715, 1048, 1512, 1751, 1752, 1753, 1963, 1998, 2174, 2256, 2384, 2486, 2487, 2741, 2760, | #2236701 |
| 01/01/2018–03/31/2018 | Firm Activity (payments) | Purdue Pharma LP | Matt Back Government Relations | $21,000 | $0 | $21,000 | $106,023 | Legislature regarding AB 2486 SB 1109 | #2240035 |